Modeling of cardiac ischaemia and reperfusion injury: a human-based in vitro model using iPS-derived cardiomyocytes

被引：0
|
作者：
Pinho, J. [1 ]
Scrimgeour, N. R. [1 ]
Stolen, T. [1 ]
Solvang-Garten, K. [1 ]
Sharma, A. [2 ]
Fonseca, D. Miranda [2 ]
Smith, G. [3 ]
Hoydal, M. [1 ]
机构：
[1] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway
[2] Norwegian Univ Sci & Technol, Prote & Metabol Core Facil PROMEC, Trondheim, Norway
[3] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1095
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [41] Using human iPS cell-derived enterocytes as novel in vitro model for the evaluation of human intestinal mucosal damage
    Kondo, Satoshi
    Mizuno, Shota
    Hashita, Tadahiro
    Iwao, Takahiro
    Matsunaga, Tamihide
    [J]. INFLAMMATION RESEARCH, 2018, 67 (11-12) : 975 - 984
  • [42] Phosphoproteomic Analysis of Insulin Action Using Human IPS-Derived Myoblasts Reveals Important Interactions between Differences Based on Insulin Sensitivity and Sex
    Haider, Nida
    Lebastchi, Jasmin
    Batista, Thiago M.
    Knowles, Josh
    Pan, Hui
    Dreyfuss, Jonathan
    Kahn, C. Ronald
    [J]. DIABETES, 2020, 69
  • [43] Mesenchymal Stromal Cells Do Not Protect Against Renal Ischaemia Reperfusion Injury in Either an In Vitro Human Model or an In Vivo Murine Model.
    Clark, C.
    Gobe, G.
    McTaggart, S.
    [J]. TRANSPLANTATION, 2014, 98 : 349 - 349
  • [44] miR-124-3p downregulates EGR1 to suppress ischemia-hypoxia reperfusion injury in human iPS cell-derived cardiomyocytes
    Yang, Qiaoke
    Murata, Kozue
    Ikeda, Tadashi
    Minatoya, Kenji
    Masumoto, Hidetoshi
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [45] Modelling ischemia-reperfusion injury (IRI) in vitro using metabolically matured induced pluripotent stem cell-derived cardiomyocytes
    Hidalgo, Alejandro
    Glass, Nick
    Ovchinnikov, Dmitry
    Yang, Seung-Kwon
    Zhang, Xinli
    Mazzone, Stuart
    Chen, Chen
    Wolvetang, Ernst
    Cooper-White, Justin
    [J]. APL BIOENGINEERING, 2018, 2 (02):
  • [46] In vitro disease model development using human induced pluripotent stem cell-derived cardiomyocytes
    Huang, Minxue
    Raghupathy, Narayanan
    Chen, Shen-Jue
    Levesque, Paul
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
  • [47] Modeling Diabetic Cardiomyopathy Model Using Human Induced Pluripotent Stem Cell-derived Cardiomyocytes
    Horikoshi, Yuichi
    Williams, Anna
    Bai, Xiaowen
    Yan, Yasheng
    Kwok, Wai-Meng
    Bosnjak, Zeliko
    [J]. CIRCULATION RESEARCH, 2016, 119
  • [48] Development of a 3D bioprinted human-based bone model using patient-derived cells
    de Leeuw, Anke
    Zhang, Jianhua
    Lim, Pei Jin
    Ruger, Matthias
    Rohrbach, Marianne
    Giunta, Cecilia
    Mueller, Ralph
    Rubert, Marina
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 302 - 303
  • [49] Implantation of human iPS cell-derived engineered cardiac tissues including cardiomyocytes and multiple vascular lineages ameliorates cardiac dysfunction after myocardial infarction in a rat model
    Masumoto, H.
    Nakane, T.
    Tinney, J.
    Yuan, F.
    Ye, F.
    Kowalski, W.
    Minakata, K.
    Sakata, R.
    Yamashita, J.
    Keller, B.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 703 - 703
  • [50] Cardiotoxicity evaluation using three-dimensional cardiac tissues consisting of human iPS cell-derived cardiomyocytes and fibroblasts by cell coating technique
    Tadano, Kiyoshi
    Kazusa, Katsuyuki
    Takamatsu, Kazuhiko
    Naraoka, Hitoshi
    Takeda, Maki
    Akashi, Mitsuru
    Miyagawa, Shigeru
    Sawa, Yoshiki
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99
12345